For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $2.32 in the prior trading day, NRX Pharmaceuticals Inc (NASDAQ: NRXP) closed at $2.6, up 12.07%. In other words, the price has increased by $12.07 from its previous closing price. On the day, 0.64 million shares were traded. NRXP stock price reached its highest trading level at $2.73 during the session, while it also had its lowest trading level at $2.28.
Ratios:
Our goal is to gain a better understanding of NRXP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.11 and its Current Ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 02, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 17 ’24 when Javitt Jonathan C bought 40,000 shares for $1.17 per share. The transaction valued at 46,800 led to the insider holds 84,634 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 61801736 and an Enterprise Value of 58177200.
Stock Price History:
The Beta on a monthly basis for NRXP is 1.63, which has changed by 0.59509206 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, NRXP has reached a high of $6.01, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -9.95%, while the 200-Day Moving Average is calculated to be 5.11%.
Shares Statistics:
The stock has traded on average 303.79K shares per day over the past 3-months and 527840 shares per day over the last 10 days, according to various share statistics. A total of 23.77M shares are outstanding, with a floating share count of 20.88M. Insiders hold about 12.16% of the company’s shares, while institutions hold 25.22% stake in the company. Shares short for NRXP as of 1755216000 were 545481 with a Short Ratio of 1.80, compared to 1752537600 on 799531. Therefore, it implies a Short% of Shares Outstanding of 545481 and a Short% of Float of 3.0299999.
Earnings Estimates
The dynamic stock of NRX Pharmaceuticals Inc (NRXP) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.21, with high estimates of $0.21 and low estimates of $0.21.
Analysts are recommending an EPS of between $0.15 and $0.15 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.5, with 1.0 analysts recommending between $0.5 and $0.5.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $15.5M. There is a high estimate of $29M for the next quarter, whereas the lowest estimate is $1M.
Based on 3 analysts’ estimates, the company’s revenue will be $127.99M in the next fiscal year. The high estimate is $241.4M and the low estimate is $42.57M.
